Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients

Published:2005-08-01 Issue:8 Volume:36 Page:709-713
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Peffault de Latour R,Asselah T,Lévy V,Scieux C,Devergie A,Ribaud P,Espérou H,Traineau R,Gluckman E,Valla D,Marcellin P,Socié G

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705120.pdf

Reference20 articles.

1. Strasser SI, Myerson D, Spurgeon CL et al. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Hepatology 1999; 29: 1893–1899.

2. Locasciulli A, Testa M, Valsecchi MG et al. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group. Transplantation 1999; 68: 1486–1491.

3. Peffault de Latour R, Levy V, Asselah T et al. Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 2004; 103: 1618–1624.

4. Poynard T, Marcellin P, Lee SS et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998; 352: 1426–1432.

5. Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958–965.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients – Study of infectious diseases working party of EBMT;Journal of Infection;2022-01

2. Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report;Journal of Infection and Chemotherapy;2021-08

3. Anti‐infective prophylaxis, immunization and prevention of late infectious complications;Blood and Marrow Transplantation Long Term Management;2021-03-19

4. Safety of allogeneic hematopoietic stem cell transplantation in beta‐thalassemia patients with chronic hepatitis C infections treated at a pediatric center;Pediatric Transplantation;2019-06-17

5. Treatment of hepatitis C in two paediatric patients using sofosbuvir during haematopoietic stem cell transplantation;Antiviral Therapy;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3